Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

China · Delayed Price · Currency is CNY

13.31

+0.14 (1.06%)

Sep 14, 2026, 3:04 PM CST

Market Cap	9.13B -28.1%
Revenue (ttm)	3.21B +16.6%
Net Income	633.36M +8.2%
EPS	0.91 +7.9%
Shares Out	693.22M
PE Ratio	14.50
Forward PE	12.66
Dividend	0.35 (2.60%)
Ex-Dividend Date	May 28, 2026

Volume	5,940,558
Open	13.16
Previous Close	13.17
Day's Range	13.12 - 13.33
52-Week Range	12.30 - 19.42
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. The company offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1995

Employees 2,861

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300181

Full Company Profile

Financial Performance

In 2025, SHE:300181's revenue was 3.04 billion, an increase of 17.96% compared to the previous year's 2.58 billion. Earnings were 631.93 million, an increase of 24.45%.

Financial Statements